Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
7.4
310.79%
80%
—
17x
60%
—
5 Years
Score7.4
Net Growth310.79%
Net Trend80%
Net Income Consistency—
Rev Growth17x
Rev Trend60%
Revenue Consistency—
Arbutus Biopharma Corp fundamental performance
Between 2020 and 2025, revenue grew from $ 6M to $ 14M and net income went from -$ 63M to -$ 33M. Revenue increased in 3 of those 5 years; net income in 4.
Between 2015 and 2025, revenue declined from $ 24M to $ 14M and net income went from -$ 61M to -$ 33M. Revenue increased in 7 of those 10 years; net income in 7.
Arbutus Biopharma Corp currently holds a 5-year HDB Score of 7.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.59 | — |
1 Year2025-08-12 | $ 3.40 | 35.00% |
5 Years2021-08-12 | $ 3.04 | 50.99% |
10 Years2016-08-12 | $ 3.80 | 20.79% |
All Time2015-08-03 | $ 10.50 | -56.29% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-08-03 |
|---|---|---|---|---|---|
| Price | $ 4.59 | $ 3.40 | $ 3.04 | $ 3.80 | $ 10.50 |
| Return | — | 35.00% | 50.99% | 20.79% | -56.29% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 191M | $ 160M | $ 95M |
| 2025 | $ 14M | -$ 33M | $ 91M |
| 2024 | $ 6M | -$ 69M | $ 122M |
| 2023 | $ 18M | -$ 72M | $ 126M |
| 2022 | $ 39M | -$ 69M | $ 146M |
| 2021 | $ 10M | -$ 76M | $ 155M |
| 2020 | $ 6M | -$ 63M | $ 123M |
| 2019 | $ 6M | -$ 153M | $ 90M |
| 2018 | $ 5M | -$ 57M | $ 124M |
| 2017 | $ 10M | -$ 84M | $ 126M |
| 2016 | $ 1M | -$ 384M | $ 130M |
| IPO2015 | $ 24M | -$ 61M | $ 181M |
Explore beyond ABUS
You're looking at Arbutus Biopharma Corp. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
